SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-024885
Filing Date
2022-06-30
Accepted
2022-06-30 08:40:16
Documents
14
Period of Report
2022-06-27
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20220627.htm   iXBRL 8-K 36108
2 EX-99.1 hrtx-ex991_6.htm EX-99.1 27962
3 GRAPHIC g2cxwlzv1ywa000001.jpg GRAPHIC 23447
  Complete submission text file 0001564590-22-024885.txt   232619

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20220627.xsd EX-101.SCH 5585
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20220627_lab.xml EX-101.LAB 19335
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20220627_pre.xml EX-101.PRE 11489
8 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20220627_htm.xml XML 3557
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 221056608
SIC: 2834 Pharmaceutical Preparations